| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/18/1997 | WO1997025268A3 Material having a substance protected by deformable standoffs and method of making |
| 09/18/1997 | WO1997025097A3 Activatable infusable dispersions and methods for using them for therapy and diagnostics |
| 09/18/1997 | WO1997025067A3 Polymers |
| 09/18/1997 | WO1997020569A3 Bioartificial devices and cellular matrices therefor |
| 09/18/1997 | WO1997007815A3 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| 09/18/1997 | DE19611769A1 Mikropartikel, Verfahren zu deren Herstellung, sowie deren Verwendung in der Ultraschall Diagnostik Microparticles, methods for their preparation, and their use in ultrasound diagnostics |
| 09/18/1997 | DE19610396A1 Topical analgesic preparations with high di:methyl sulphate content |
| 09/18/1997 | CA2248932A1 Oligonucleotides targeted to angiotensinogen mrna |
| 09/18/1997 | CA2248881A1 Ophthalmological composition of the type which undergoes liquid-gel phase transition |
| 09/18/1997 | CA2248739A1 Microparticles, process for their production, and their use in ultrasound diagnosis |
| 09/18/1997 | CA2248567A1 Process for preparing a storable preparation consisting of fresh plants, and fresh plant preparation |
| 09/18/1997 | CA2248158A1 Targeted site specific drug delivery compositions and method of use |
| 09/18/1997 | CA2248076A1 Polymeric delivery of radionuclides and radiopharmaceuticals |
| 09/18/1997 | CA2247986A1 Alginate containing antimicrobial composition |
| 09/18/1997 | CA2247432A1 Targeting macromolecular prodrugs to t lymphocytes |
| 09/18/1997 | CA2247431A1 Adhesive compositions including polyvinylpyrrolidone, acrylic acid polymers, and polyamines |
| 09/17/1997 | EP0795585A1 Finely divided suspensions of carotenoids or retinoids and process to manufacture them |
| 09/17/1997 | EP0795561A1 Novel anthracycline compound derivatives and medicinal preparations containing the same |
| 09/17/1997 | EP0795325A1 Plasmid entrapping multilamellar liposomes |
| 09/17/1997 | EP0795324A2 A pharmaceutical tablet characterized by a showing high volume increase when coming into contact with biological fluids |
| 09/17/1997 | EP0795323A1 Stable gelified composition containing oxygen- and/or water-sensitive lipophilic actives |
| 09/17/1997 | EP0795322A1 Composition thickened with an alkylether of a polysaccharide |
| 09/17/1997 | EP0795321A1 Stable gelified water in oil emulsion |
| 09/17/1997 | EP0795320A1 Stable gelified composition with high electrolyte content |
| 09/17/1997 | EP0794908A1 Packaging for patches |
| 09/17/1997 | EP0794798A2 Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy |
| 09/17/1997 | EP0794797A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 09/17/1997 | EP0794795A1 Dispensing unit containing a particulate product for the administration of drugs or nutrient preparations to animals and process for the manufacture of the particulate product |
| 09/17/1997 | EP0794794A1 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 09/17/1997 | EP0794791A1 New therapeutical utilization of superoxide dismutases |
| 09/17/1997 | EP0794790A1 Localized delivery of factors enhancing survival of transplanted cells |
| 09/17/1997 | EP0794786A1 The use of inositoltrisphosphate for the preparing of medicaments |
| 09/17/1997 | EP0794783A1 Cyclodextrins as suspending agents for pharmaceutical suspensions |
| 09/17/1997 | EP0794778A1 Resin particle, medical material and pharmaceutical preparation containing said resin particle |
| 09/17/1997 | EP0794777A1 Lubeluzole intravenous solutions |
| 09/17/1997 | EP0794770A1 Transdermal preparation containing a loratidine metabolite with antihistaminic activity |
| 09/17/1997 | EP0794769A1 Method of drug delivery and coatings for use in the method |
| 09/17/1997 | EP0794768A1 A ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating |
| 09/17/1997 | EP0794767A1 Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams |
| 09/17/1997 | EP0755675B1 Dermatological and/or pharmaceutical composition, process of preparation and utilization |
| 09/17/1997 | EP0721328A4 Camptothecin formulations |
| 09/17/1997 | EP0707475B1 Extended release, film-coated tablet of astemizole and pseudoephedrine |
| 09/17/1997 | EP0689423B1 Aerosol formulation containing a diol-diacid derived dispersing aid |
| 09/17/1997 | EP0687173B1 Synthetic particulate vectors and method for preparing same |
| 09/17/1997 | EP0660704B1 A process for producing suppositories by compression and suppositories obtained by the process |
| 09/17/1997 | EP0648114B1 Liposomes, method of preparing them and their use in the preparation of drugs |
| 09/17/1997 | EP0646001B1 Bioresorbable polymer microspheres free from surface active agents, their preparation and application as drug |
| 09/17/1997 | EP0634937B1 Vaccines containing non-ionic surfactant vesicles |
| 09/17/1997 | EP0615442B1 Sol-controlled gelatine-based thermocolloidal matrix for peroral prolonged action administration forms |
| 09/17/1997 | EP0610357B1 Transdermal therapeutic systems containing crystallization inhibitors |
| 09/17/1997 | EP0607128B1 Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals |
| 09/17/1997 | EP0590060B1 Orally administrable therapeutic proteins and method of making |
| 09/17/1997 | EP0460020B2 Drug delivery compositions |
| 09/17/1997 | CN1159761A Vaccine compositions |
| 09/17/1997 | CN1159759A Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 09/17/1997 | CN1159754A Improved pharmaceutical formulations containing ibuprofen and codeine |
| 09/17/1997 | CN1159753A Anti-acne cosmetic compositions |
| 09/17/1997 | CN1159350A Standard technological method of moderately substituted carboxymethyl starch copper used in dispersant sheet |
| 09/17/1997 | CN1159345A Traditional Chinese medicine of set prescription with function of promoting intelligence and prolonging life-span |
| 09/17/1997 | CN1159342A External medicinal stick for treating aphthae and preparation method thereof |
| 09/17/1997 | CN1159338A Anti-radiation health care liquid and preparation method thereof |
| 09/17/1997 | CN1159336A Medicine for treating leukoderma |
| 09/17/1997 | CN1159334A Quick healing ointment for scald |
| 09/17/1997 | CN1159333A Oral liquid for promoting milk secreting and production method thereof |
| 09/17/1997 | CN1159332A Cap for preventing and curing cerebral hemorrhage |
| 09/17/1997 | CN1159323A Medicinal compositionf or preventing and curing xerophthalmia and disease led themby, method and apparatus |
| 09/17/1997 | CN1035859C Metronidazoli hydrochloride intramuscular injection |
| 09/16/1997 | US5668183 Water dispersible compositions |
| 09/16/1997 | US5668170 Composition and method enhancing transdermal electrotransport agent delivery |
| 09/16/1997 | US5668168 1,2-dithiin antiinfective agents |
| 09/16/1997 | US5668130 Medicament for treating gastrointestinal disorders |
| 09/16/1997 | US5668120 Iontophoretic delivery of bisphosphonates to the alveolar bone |
| 09/16/1997 | US5668119 Topical pharmaceutical containing heparin and method of treatment |
| 09/16/1997 | US5668111 Sustained-release preparation |
| 09/16/1997 | US5667981 Diagnostics and treatments for cancers expressing tyrosine phosphorylated CRKL protein |
| 09/16/1997 | US5667809 Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents |
| 09/16/1997 | US5667808 Metal ion complex |
| 09/16/1997 | US5667807 Thermal granulation process |
| 09/16/1997 | US5667806 Spray drying method and apparatus |
| 09/16/1997 | US5667805 Morphine therapy |
| 09/16/1997 | US5667804 Matrix with drug and coating |
| 09/16/1997 | US5667803 Excipient in controlled release formulations, adjusting degree of substitution and compression force to control release properties |
| 09/16/1997 | US5667802 Antacid composition |
| 09/16/1997 | US5667801 Sustained release heterodisperse hydrogel systems for insoluble drugs |
| 09/16/1997 | US5667800 Lotions with lipids and emulsifiers |
| 09/16/1997 | US5667798 Transdermal drug delivery system |
| 09/16/1997 | US5667789 Emulsifier free, cosmetic and dermatological compositions, treatment of acne, aging |
| 09/16/1997 | US5667775 Phosphate-binding polymers for oral administration |
| 09/16/1997 | US5667773 Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith |
| 09/16/1997 | US5667573 Erythritol, water soluble cellulose, drugs, foods |
| 09/16/1997 | US5667492 Use and composition of an anti-sexually transmitted diseases formulation |
| 09/16/1997 | CA2166483C New pharmaceutical formulation |
| 09/16/1997 | CA1339463C Effervescent tablet containing a salicylic acid-forming agent |
| 09/15/1997 | CA2200012A1 Plasmid entrapping multilamellar liposomes |
| 09/12/1997 | WO1997032895A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 09/12/1997 | WO1997032614A1 Microdispersions for coating surgical devices |
| 09/12/1997 | WO1997032606A1 Pharmaceutical compositions containing buffered ortho ester polymers |
| 09/12/1997 | WO1997032596A1 Intercellular adhesion molecule powder formulation |
| 09/12/1997 | WO1997032584A1 Slow-release pharmaceutical formulations containing mizolastin |
| 09/12/1997 | WO1997032573A1 Modified release multiple-units dosage composition |